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CIRRHOSIS AND CARCINOMA 
Treatment of cirrhotic rats with epidermal growth factor and 
insulin accelerates liver DNA synthesis after partial hepatectomy 
MASAJI HASHIMOTO, PIYUSH C KOTHARY AND FREDERIC E ECKHAUSER AND 
STEVEN E RAPER 
Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA 
Abstract Prevention of postoperative hepatic failure is important after hepatic resection. In patients 
with cirrhosis, impaired liver function and regenerative capacity after major hepatic resection are asso- 
ciated with increased morbidity and mortality. In this study, a combination of epidermal growth factor 
(EGF) and insulin were used as hepatotrophic factors in an attempt to stimulate DNA synthesis after 
70% hepatectomy (HTX). Regenerative capacity was evaluated in normal and cirrhotic rat liver by mea- 
suring DNA synthesis in vivo. Micronodular liver cirrhosis was established by the simultaneous oral 
administration of CC14 and phenobarbital. Epidermal growth factor plus insulin was injected subcuta- 
neously immediately after and 12 h after HTX or sham operation was performed. Rats were killed 
24 h after the operation and liver regeneration was estimated by ['HI-thymidine incorporation into DNA 
as well as an autoradiographic nuclear labelling index. Hepatectomy increased [3H] -thymidine incor- 
poration significantly in both normal and cirrhotic rats. In cirrhotic rats, ['HI -thymidine incorporation 
after HTX was significantly lower than in normal rats and administration of a combination of EGF and 
insulin after HTX enhanced [3H]-thymidine incorporation. In conclusion, DNA synthesis 24 h after 
HTX is decreased in cirrhotic rats compared with normal rats and EGF supplementation with insulin 
accelerates DNA synthesis in hepatectomized cirrhotic rats. The data suggest that administration of 
combinations of exogenous hepatotrophic factors may play a useful role in the treatment of cirrhotic 
patients undergoing major hepatic resection. 
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INTRODUCTION 
Partial hepatic resection is a mainstay of treatment for 
liver tumours; however, many tumours arise in the 
setting of cirrhosis and diminished hepatic reserve. 
Normal liver usually has sufficient regenerative capac- 
ity to permit resection of up to 70% of the total liver 
cell mass. In liver cirrhosis, impaired liver function and 
poor regenerative capacity after hepatectomy (HTX) 
leads to increased morbidity and mortality.''2 There 
have been few attempts to improve hepatic regeneration 
in the cirrhotic liver.394 Utilizing a rat liver model of 
micronodular cirrhosis, established by the simultaneous 
oral administration of carbon tetrachloride (CClJ and 
phenobarbital, supplemental transforming growth 
factor alpha (TGFa) enhanced liver regeneration as 
measured by in vivo [3H]-thymidine incorporation into 
DNA.4 Epidermal growth factor (EGF) is an hepa- 
totrophic factor which promotes DNA synthesis in rat 
isolated hepatocytes and regenerating rat liver after 70% 
HTX5-7 and which shares amino acid homology with 
TGFa.' Epidermal growth factor has been shown to 
have synergistic effects on liver regeneration when sup- 
plemented with insulin or glucagon in normal rats in 
V ~ V O . ~  To determine if EGF alone or in combination 
with insulin increased DNA synthesis in cirrhotic rat 
liver, hepatic regeneration was evaluated by measure- 
ment of liver DNA synthesis using two independent 
parameters, [3H]-thymidine incorporation into DNA 
and a nuclear labelling 
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METHODS 
Chemicals 
Epidermal growth factor (fragment 20-31; EGF) and 
bovine insulin were purchased from Sigma Chemical 
Co. (St Louis, MO, USA). [Methyl-3H]-thymidine 
(37 MBqlmL) was fiom Amersham (Arlington Heights, 
IL, USA). 
Establishment of cirrhosis in a rat model 
Male Wistar rats (150-2OOg) were obtained from 
Charles River Laboratories (Wilmington, MA, USA). 
Micronodular cirrhosis was established according to the 
method of Proctor and Chatamra, by the simultaneous 
oral administration of CCl, and phenobarbital, which 
increases the sensitivity of the liver to C C 4  by induc- 
tion of the microsomal hydroxylating enzyme system." 
Rats were given phenobarbital sodium (35mddL) in 
drinking water. After treatment for 10-14 days with 
phenobarbital sodium, the rats weighed 250-300 g. The 
rats were anaesthetized with isoflurane and oxygen 
anaesthesia" and CCl, was administered once a week 
at midday using a curved feeding needle (16 gauge). 
After the beginning of CCl, feeding, bodyweight was 
measured daily. The initial dose of C C 4  was 0.04mL 
and successive doses were administered according to 
daily weight fluctuations in each rat. If bodyweight 
increased, the dose of CCl, was increased 0.04mL 
per week. If bodyweight decreased, administration of 
C C 4  was decreased to 0.02mL or stopped for the 
week. Administration of CCl, lasted for 10 weeks and 
phenobarbital was continued throughout the period of 
C C ,  gavage. Both CCl, and phenobarbital were dis- 
continued at least 2 weeks before the operation. 
Partial hepatectomy and sham operation 
Cirrhotic and normal rats were anaesthetized by 
isoflurane/Oz anaesthesia" and subjected to sham oper- 
ation or 70% hepatectomy. Sham rats were subjected to 
laparotomy and manipulation of the liver. Hepatectomy 
was performed after the method of Higgins and Ander- 
son between 08:OO and 12:OOh and resected liver was 
weighed." 
Measurement of DNA synthesis 
Sham-operated and hepatectomized normal and cir- 
rhotic rats were randomly placed in one of four groups. 
Group A, sham operated, no treatment (normal rats 
n = 9, cirrhotic rats n= 6); group B 70% HTX, no treat- 
ment (normal rats n=9, cirrhotic rats n=7); group C 
70% HTX, subcutaneous injection of EGF 
(30nmoYkg) just after and 12h after 70% HTX 
(normal rats n = 3, cirrhotic rats n = 3); group D 70% 
HTX, subcutaneous injection of EGF and insulin 
(30 nmolkg and 0.2 nmol/kg) just after and 12 h after 
HTX (normal rats n=4, cirrhotic rats n=5). 
All rats were killed 24 h after the Operation and the 
remnant liver and spleen were excised and weighed. 
Blood samples were collected from the inferior vena 
cava and serum albumin, total bilirubin and glucose 
were measured using commercial kits (Sigma Chemical 
Co., St Louis, MO, USA). Serum insulin was measured 
by radioimmunoassay as performed by the Michigan 
Diabetes Research and Training Center. Liver DNA 
synthesis 24h after hepatectomy was assessed using 
[3H]-thymidine incorporation. [3H] -Thymidine was 
injected intravenously 1 h before the rats were killed.@ 
A 0.5 mL aliquot of liver homogenate (using a Dounce- 
type homogenizer; Sigma) was precipitated with ice- 
cold 10% trichloroacetic acid twice and 70% ethanol 
once. [3H]-Thyrnidine radioactivity in the precipitate 
was measured with a Beckman LS 6000LL liquid scin- 
tillation counter (Beckman Instruments Inc., Fullerton, 
CAY USA). A separate 0.1 mL aliquot was analysed to 
measure DNA using a modified diphenylamine reaction 
for des~xypentose.'~ Data were expressed as c.p.m./pg 
DNA. To minimize variations in the specific activity of 
the lots of [3H]-thymidine used, [3H]-thymidine incor- 
poration into DNA was expressed as a percentage of 
[3H]-thymidine incorporation into DNA of sham- 
operated, non-cirrhotic rat liver. 
To corroborate the observed results of [3H]- 
thymidine incorporation into DNA, autoradiographic 
analysis was performed and a nuclear labelling index 
was calculated. Tissue samples were fixed in 10% 
neutral-buffered formalin and embedded in paraffin 
blocks. Sections were cut, dipped in Kodak NTB-3 
emulsion (Eastman Kodak, Rochester, NY, USA) and 
exposed for 4 weeks. Slides were developed in Dektol, 
counterstained with haematoxylin and eosin and 
analysed under the microscope with a 40x objective 
lens. Approximately 1000 nuclei were scored per exper- 
imental condition and the percentage of total nuclei 
positive for silver grains was used to calculate the 
labelling index. 
statistical analysis 
All values shown represent the mean + SEM. Student's 
t-test was used for comparing group means. The level 
of significance was accepted at P< 0.05. 
RESULTS 
Establishment of liver cirrhosis in rats 
Thirty-four rats were treated with C C 4  and phenobar- 
bital. These rats gained significantly less weight than 
untreated rats (Fig. 1). Overall mortality was 18% 
(6/34). All animals treated had macroscopic changes of 
the liver compatible with micronodular cirrhosis. 
Ascites developed during CCl, treatment in five treated 
rats (15%) but disappeared when the dose of CCll was 
reduced or stopped.Three treated rats (9%) were noted 
to have ascites at the time of operation. Abdominal wall 
or intra-abdominal collateral vessels or a dilated splenic 
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Figure 1 Bodyweight change in experimental animals. All rats were weighed daily after beginning the administration of carbon 
tetrachloride (CCI,). Bodyweight change, compared with starting bodyweight, is expressed on the ordinate. Points are means of 
cirrhotic rats (6, n = 16) or normal controls (0, n = 5) .  Error bars represent SEM. 
Table 1 
mental animals 
Biological and biochemical parameters of experi- 
Figure 2 Histology of CC1,-treated cirrhotic rat liver. This 
section of liver demonstrates established micronodules of liver 
separated by the thick bands of fibrous scar (Mallory's 
trichrome stain). 
vein were observed in all rats. The overall effectiveness 
of this method for creating liver cirrhosis was 82% 
(28134). Figure 2 is representative of the typical micro- 
scopic features of cirrhosis found in these rat livers. 
Characteristics of rats with liver cirrhosis 
To corroborate the gross and microscopic features of 
cirrhosis in the treated rats, selected biological and 
Normal rats Cirrhotic rats 
(n = 25) (n=21) 
Bodyweight (g) 589f 12 463 k 19* 
Anterior lobe of liver (gl1OOg 2.51 fO.10 2.54k0.16 
Spleen (mg/lOO g bodyweight) 220 f 8 286 f 28* 
Albumin (gldL) 4.00f0.20 3.41 k0.16* 
Total bilirubin (mg/dL) 0.15 f0.05 0.40f 0.10* 
bodyweight) 
~~ 
Data are expressed as meanfSEM. *P<O.O5 versus 
normal rats. 
biochemical parameters were measured (Table 1). The  
splenic weight of cirrhotic rats was greater than normal 
rats. Serum albumin of cirrhotic rats at time of death 
was less than normal rats. The serum total bilirubin of 
cirrhotic rats at death was greater than in normal rats. 
Insulin levels in normal or cirrhotic rats subjected to 
70% hepatectomy treated with EGF alone or EGF plus 
insulin were lower than in normal or cirrhotic sham- 
operated rats (Table 2). Subcutaneous injection of 
insulin (0.2 nmol/kg) had no  effect on plasma insulin 
levels between EGF-treated rats and EGF plus insulin- 
treated rats. T h e  serum glucose level after death is 
shown in Table 2. The  glucose level of rats treated with 
70% HTX, EGF and insulin was significantly less than 
in normal sham rats. 
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Table 2 Serum insulin and glucose level 24 h after operation 
Insulin (punits/mL) Glucose (mg/dL) 
Sham HTX + EGF HTX + EGF + Ins Sham HTX+EGF HTX + EGF + Ins 
Normal rats 12.6f1.7 6.2 f 0.6* 5.0f 1.0* 156f9 13623 113f14* 
Cirrhotic rats 18.8f2.7 7.620.9* 8.8 f 1 .O* 143f 1 134f 13 123f 14 
Data are expressed as mean? SEM. *P< 0.05 versus sham-operated rats in each group. HTX, 70% hepatectomy; EGF, epi- 
dermal growth factor; Ins, insulin. 
DNA synthesis after sham operation 
and 70% hepatectomy 
Twenty-four hours after 70% HTX, [3H]-thymidine 
incorporation into the liver of normal rats was 
significantly increased from 100 f 3% (normal sham) to 
928f 148%, which was 9.3-fold that of normal sham 
rats (Fig. 3a). In rats with normal liver, exogenous EGF 
without supplemental insulin did not enhance [3H]- 
thymidine incorporation after 70% HTX (857 f 101%), 
whereas exogenous EGF with insulin did (1625f 
519%), but not significantly (Fig. 3a). After 70% HTX 
in cirrhotic rats, ['HI-thymidine incorporation into the 
liver also significantly increased from 77 f 8% (cirrhotic 
sham) to 284+59% (cirrhotic HTX), 3.7-fold that 
of cirrhotic sham rats (Fig. 3b). These levels of [3H]- 
thymidine incorporation were significantly lower than in 
rats with normal liver (928 f 148%). The combination 
of exogenous EGF and insulin significantly improved 
[3Hl-thymidine incorporation in cirrhotic rat liver (284 
f 59 vs 706 f 186%). Exogenous EGF alone had no 
growth-promoting effect on cirrhotic liver after 70% 
HTX (204 f 57% vs 284 f 59%). 
Thymidine autoradiography 
To support the results of [3H]-thymidine incorporation, 
autoradiography was performed and a nuclear labelling 
index was calculated for both normal and cirrhotic rat 
liver. Over 1000 nuclei were analysed in tissue sections 
of individual or duplicate rats with normal or cirrhotic 
liver subjected to sham or 70% HTX. In rats with 
normal liver subjected to sham or 70% HTX, the 
labelling index was < 1 and 23%, respectively. Qualita- 
tively, no positive nuclei were seen in cirrhotic rats sub- 
jected to sham hepatectomy. In cirrhotic liver from 70% 
HTX, the labelling index was 5%. A further marked 
increase in the labelling index of liver from hepatec- 
tomized cirrhotic rats treated with supplemental EGF 
and insulin (14%) was also noted. Representative 
autoradiographs of regenerating cirrhotic rat liver 
treated with EGF and insulin or without treatment are 
shown in Fig. 4(a,b). 
DISCUSSION 
Previous experiments using the cirrhotic rat model 
described in this report have shown a beneficial effect 
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Figure 3 (a) ['HI-Thymidine incorporation into normal rat 
liver 24 h after hepatectomy. In rats with normal liver, ['HI- 
thymidine incorporation was significantly increased when 
sham hepatectomy (0) was compared to 70% hepatectomy 
(HTX, 0; *P<0.05). Exogenous EGF with (m) or without 
(NI) insulin was not significantly different from controls. (b) 
['HI-Thymidine incorporation into cirrhotic rat liver 24 h after 
hepatectomy. In hepatectomized cirrhotic rats, ['HI-thymidine 
incorporation into saline-treated liver was significantly 
increased from 77 t 8% (sham, 0) to 284 f 59% (70% HTX, 
0; P< 0.05. Exogenous EGF plus insulin (m) increased ['HI- 
thymidme incorporation to 706f 186% when compared with 
saline-treated cirrhotic liver subjected to 70% HTX (*P< 
0.05). Exogenous EGF alone (NI) had no significant effect on 
['HI-thymidine incorporation into cirrhotic liver after 70% 
HTX. 
thesis after 70% H l X 4  The phenobarbital/CC14 cir- 
rhotic rat model used in the present study was relatively 
easy to create and established micronodular cirrhosis 
with a high yield." The characteristic features of liver 
histology, splenomegaly and dilated portal collateral cir- 
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Figure 4 Autoradiographs of [3H]-thymidine incorporated 
into cirrhotic rat liver. Representative autoradiographs of 70% 
hepatectomized cirrhotic rat liver treated with (a) epidermal 
growth factor and insulin or (b) without treatment. 
culation were similar to those seen in humans with 
cirrhotic liver and portal hypertension. Hypoalbu- 
minaemia and hyperbilirubinaemia are compatible with 
impaired liver function as well as structure. In addition, 
the present study confirms impaired liver DNA synthe- 
sis after 70% HTX in this cirrhotic rat model. 
In normal liver, the rate of DNA synthesis after 70% 
HTX reaches a maximum at 24 h after operation and 
in cirrhotic liver the process of liver regeneration after 
70% HTX was prolonged.'JJ4 In this study, ['HI- 
thymidine incorporation into DNA 24h after 70% 
HTX was used to evaluate liver regenerati0n.Thi.s para- 
meter has been established to be a useful indicator of 
the effect of growth factors on cell proliferation in a 
variety of experimental  system^.^'^'^ To minimize varia- 
tion in the specific activity of the lots of [3H]-thymidine 
used, ['HI-thymidine incorporation into DNA was 
expressed as a percentage of [3H] -thymidine incorpora- 
tion into DNA of sham-operated normal rat liver and 
liver regeneration in both normal and cirrhotic rats 
could be evaluated quantitatively. 
We hypothesized that EGF could be used as an hepa- 
totrophic factor in cirrhotic rat liver. In the experiments 
reported here, the combination of EGF and insulin 
enhanced liver DNA synthesis in cirrhotic rats. Some- 
what unexpectedly, treatment of rats with EGF alone 
(30nmoYkg) did not result in improved DNA synthe- 
sis after 70% HTX in normal or cirrhotic rats, which is 
consistent with the results of Olsen et aL7 Epidermal 
growth factor required supplemental insulin or 
glucagon to accelerate liver DNA synthesis after hepa- 
tectomy in normal rats;7 hence, treatment with EGF 
and insulin were used in this study. We chose the dose 
of EGF, 30 nmoYkg, in accordance with the 1iteratu1-e.~ 
Rasmussen et al. reported that a higher dose of EGF 
(48 nmoYkg) was ineffective, but that smaller doses can 
stimulate liver regeneration: the cause of this has not 
been elucidated. "Two normal non-hepatectomized rats 
(normal sham) were treated with EGF (30 nmol/kg) 
and insulin (0.2nmoYkg) and had a [3H]-thymidine 
uptake of 84 zk 17%, which indicated that this treatment 
did not stimulate DNA synthesis in non-HTX rats. 
Although insulin is an hepatocyte growth modulator, 
a number of lines of evidence suggest that treatment 
with insulin alone has limited or no benefit in normal 
regenerating 1i~er . I~ Insulin is considered to be essential 
in liver regeneration and is transported into liver during 
the process of liver regeneration.I6 Insulin levels are 
reported to be high in cirrhotic patients and peripheral 
glucose metabolism suggests an impaired insulin 
response. I 7 , l 8  Insulin-stimulated glycogen formation has 
been shown to be markedly impaired." D'Arville et d. 
reported that insulin levels of CClJphenobarbital- 
induced cirrhotic rats were not significantly altered 
when compared with phenobarbital-treated rats." 
Shankar et al. reported that insulin levels in 
thioacetamide-induced cirrhotic rats were significantly 
higher than in normal rats.*'There may be a disturbance 
of the uptake of insulin in cirrhotic liver, possibly by 
receptor-mediated mechanisms." After partial hepate- 
ctomy, insulin levels have been reported to decline and 
the administration of exogenous insulin results in little 
or no regenerative In normal rats, decreased 
insulin and elevated glucagon levels have characterized 
the hepatic proliferative state.I6 In the present study, 
insulin levels in hepatectomized rats were significantly 
lower than in sham-operated rats with normal or cir- 
rhotic liver and serum insulin and glucose levels were 
measured in treated and untreated normal and cirrhotic 
rats and found to be unchanged by the doses of insulin 
administered. Confirming the findings of the previously 
mentioned studies, insulin levels in cirrhotic sham rats 
were increased when compared with normal sham rats. 
The hyperinsulinaemia seen in these cirrhotic rats was 
not observed to have a cooperative effect with EGF in 
the acceleration of DNA synthesis. With regards to the 
effect of insulin alone on liver regeneration, one cirrhotic 
rat, treated preliminarily only with insulin (0.2 
nmoYkg), had a ['HI-thymidine uptake level of 398% 
of the normal sham-control rat compared to saline- 
treated hepatectomized cirrhotic rats at a level of 284 * 
59%. This was in contrast to the data on EGF and 
insulin, which gave a thymidine uptake value of 706f 
186%. Due to this preliminary result and hyperinsuli- 
naemia in cirrhotic rats, we did not use insulin alone on 
cirrhotic rats. 7 ~ 1 8  
There are few studies which correlate the effect of 
hepatotrophic factors in cultured hepatocytes and in 
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vim studies. In monolayer cultures of isolated hepato- 
cytes, EGF alone has a stimulatory effect on DNA syn- 
thesis and EGF supplemented by insulin markedly 
accelerates DNA s y n t h e s i ~ . ~ ~ ~ ~  The observed differences 
in the effects of EGF on isolated hepatocytes and hepa- 
tocytes in vivo are not well understood. Cellular density, 
or contact inhibition, the hormonal milieu and inner- 
vation of the liver in situ and damage during cell isola- 
tion might all play a role in the divergent responses seen 
in isolated hepatocytes and liver in viva 
Epidermal growth factor and TGFa are similar in 
that they share a 3344% homology in amino acid 
sequence and bind the same cell surface 
Transforming growth factor a has a limited effect on 
liver regeneration in normal rats, but does have a stim- 
ulatory effect in cirrhotic liver.4 Epidermal growth 
factor alone has no effect in cirrhotic liver. In vim, 
TGFa, acting in an autocrine manner, appears to be 
the physiological peptide hormone and EGF, acting via 
either an endocrine or paracrine mechanism, also 
appears to be the physiological peptide hormone.24iz5 
The reasons for the disparity in the effects of EGF and 
TGFa are not known. The effects of EGF and TGFa 
on liver regeneration cannot be quantitatively com- 
pared, because the true physiological doses are not 
known. Further, although EGF and TGFa bind the 
same receptor in plasma membranes,' there is evidence 
that EGF and TGFa have different post-receptor path- 
ways of signal transduction. Insulin appears necessary 
for normal signal transduction by EGF.26327 It is tempt- 
ing to speculate that the transforming properties of 
TGFa in vim0 may be related to the lack of a require- 
ment for additional regulatory factors, such as insulin. 
One potential drawback in the use of these growth 
factors in clinical trials is the potential for neoplastic 
transformation. Undetectable neoplasm or metastases 
in the remnant liver might be stimulated to grow by 
treatment of growth factors. 
In conclusion, DNA synthesis 24 h after 70% HTX 
was significantly decreased in cirrhotic rats compared 
with normal rats. Combined treatment with EGF and 
insulin accelerated DNA synthesis in hepatectomized 
cirrhotic rats. Ultimately, such a combination of growth 
factor therapy may prove useful in the support of cir- 
rhotic liver where regeneration must occur to allow 
patient survival. 
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